## Abstract Using endothelial cells for therapeutic angiogenesis/vasculogenesis of ischemia diseases has led to exploring human embryonic stem cells (hESCs) as a potentially unlimited source for endothelial progenitor cells. With their capacity for selfβrenewal and pluripotency, hESCs and their der
Vascular engineering using human embryonic stem cells
β Scribed by Donny Hanjaya-Putra; Sharon Gerecht
- Publisher
- American Institute of Chemical Engineers
- Year
- 2009
- Tongue
- English
- Weight
- 597 KB
- Volume
- 25
- Category
- Article
- ISSN
- 8756-7938
- DOI
- 10.1002/btpr.129
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Induced pluripotent stem cell (iPSC) technology has emerged as the most promising method for generating patientβspecific human embryonic stem (ES) cells and adult stem cells (Takahashi et al., 2007, Cell 131:861β872; Wernig et al., 2007, Nature 448:318β324; Park et al., 2008, Nature 451
## Abstract Availability of human embryonic stem cells (hESC) has enhanced human neural differentiation research. The derivation of neural progenitor (NP) cells from hESC facilitates the interrogation of human embryonic development through the generation of neuronal subtypes and supporting glial ce
## Abstract Human embryonic stem (HES) cells are pluripotent and give rise to any cell lineage. More specifically, how the first embryonic lineage (i.e., cardiac lineage) is acquired remains in many aspects questionable. Herein, we summarize the protocols that have been used to direct the fate of H